Kymera Therapeutics Inc (NAS:KYMR)
$ 31.56 -0.55 (-1.71%) Market Cap: 1.94 Bil Enterprise Value: 1.54 Bil PE Ratio: 0 PB Ratio: 2.72 GF Score: 60/100

Q1 2024 Kymera Therapeutics Inc Earnings Call Transcript

May 02, 2024 / 12:30PM GMT
Release Date Price: $36.3 (+0.17%)
Operator

Good day and welcome to the Kymera Therapeutics first-quarter 2024 results conference call. (Operator Instructions)

Please note that this event is being recorded. I would now like to turn the conference over to Justine Koenigsberg. Please go ahead.

Justine Koenigsberg
Kymera Therapeutics Inc - Vice President, Investor Relations

Thank you. Good morning and welcome to Kymera's quarterly update call. Joining me this morning are Nello Mainolfi, President and CEO; Jared Gollob, our Chief Medical Officer; and Bruce Jacobs, our Chief Financial Officer.

Following our prepared remarks, we will open the call to questions. To have enough time to address everyone's questions, we ask that you please limit your questions to one and a relevant follow-up.

Before we begin, I would like to remind you that today's discussion will include forward-looking statements about our future expectations, plans, and prospects. These statements are subject to risks and uncertainties that may cause actual results to differ materially from those projected. A

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot